Deloitte report offers guidance for FDA ' s upcoming software regulation pathway

A recently released analysis report from the Deloitte Center for Government Insights that examines the US ’s current and proposed software as a medical device (SaMD) regulatory landscape, and includes suggestions on how the FDA’s pre-certification pilot program and other initiatives could better serve this fast-moving industry.
Source: mobihealthnews - Category: Information Technology Source Type: news